Challenges and Barriers to 503B Compounding
Ernest P. Gates Jr., president, CEO, Gates Healthcare Associates, lays out some of the biggest hurdles to bulk compounding.
The Importance of Compounding for Personalized Care
Lawrence Maida, proprietor, pharmacist in charge, Maida Pharmacy and Compounding Center, discusses some of the reasons why compounding is vital for keeping healthcare personal.
Compounding Video Roundtable
Fred Gebhart, Drug Topics contributing editor, lays out the history of compounding and introduces three experts in the pharmaceutical compounding field.
Potential Treatment for Traumatic Brain Injury Receives Regenerative Advanced Therapy Designation
Derived from cultured adult bone marrow-derived mesenchymal stem cells that have undergone temporary genetic modification.
New Video Marketing Tools
Ensuring your pharmacy’s video marketing dusts the competition has never been more important.
At a Glance: Asthma Biologics
Obinutuzumab Receives Breakthrough Therapy Designation from FDA
Monoclonal antibody shows potential for lupus nephritis treatment.
Antimicrobial Stewardship: Protecting Global Health
Programs shown to improve patient outcomes, reduce antibiotic resistance, and decrease healthcare costs.
Antibiotic Counseling Pearls for the Community Setting
Vaccinations Are Increasingly Important as Hepatitis A Epidemic Grows
23,600 cases across 29 states since 2016.
FDA Approves First Drug Under Project Orbis
Combination therapy for advance endometrial carcinoma.
Top Challenges in Managing Diabetes
Cost, education, self-monitoring, and more.
Fear Motivates Vaccinations, New Study Finds
Fear, one's faith in the government, and likelihood of exposure are leading factors.
Optimism for AI in Cancer Care
Oncologists recognize the potential of artificial intelligence (AI) in improving the quality of care and patient outcomes according to new research.
New Drug Review: Pretomanid for Highly Drug Resistant Tuberculosis
Indicated as part of a three-drug oral combination.
Oncology Market Remains Robust, Says Report
The 2018 oncology drug market had a record number of new treatments and continued a trend of growth.
Tenapanor Approved for Adults with IBS-C
NHE3 inhibitor administered as 50 mg oral tablets.
Asthma Care Complications
New medications and treatment guidelines
FDA Warns of NDMA Traces in Ranitidine Products
Patients are still allowed to take medicines as prescribed.
DEA to Slash Opioid Production
Fentanyl, oxymorphone, and hydrocodone face greatest cuts.
Opinion: Patient-Centered Care and the Heart of Independents
"Community pharmacies have reasons to be optimistic..." writes Jhaveri.
Senate Finance Committee Wants Trump Action on DIR Fees
Eight pharmacy groups lauded a letter urging the Trump administration to reform direct and indirect remuneration (DIR) fees.
MS Drugs in the Pipeline
Current phase 3 studies investigative novel, preventative approaches.
FDA Grants Tepotinib Breakthrough Therapy Designation
Investigational oral MET kinase inhibitor from Merck.
CDC, AAP Release New Childhood Flu Vaccine Recommendations
The age indication for some influenza vaccines has been expanded.
Generics and Biosimilars Facing Formulary Difficulties
New changes are making it more difficult for generics and biosimilars to compete on formularies.
Clinical Services Result in Staffing Evolutions
Technicians, clerks, even front-end cashiers are taking on new responsibilities.
Support Staff Training Resources
FDA Approves New Generic for Rare HT-1 Disorder
Oral supplements for metabolic disorder.
Nintedanib Approved for Rare Lung Disease
Oral kinase inhibitor for SSc-ILD.
